23 June 2023
The Centre for Epidemiology (VA) major 10-year impact report: data from the BSRBR-RA and UK JIA Register is helping to improve patient care.
The UK Research in Musculoskeletal Epidemiology (UK-RiME) Annual Research Showcase 2023 and the 10th anniversary of the Centre for Epidemiology Versus Arthritis (VA) resumes again today for day two of sessions with leading UK-RiME researchers, workshops, and special guests. It coincides with the publication of an impact report on The Centre’s research impact over the last ten years.
The report explains how the Centre for Epidemiology has hosted the work of the BSRBR-RA and UK JIA Registers. These world-leading registers are our best chance of being able to predict those who are most at risk of developing more serious forms of arthritis, as well as those most at risk of medication side-effects, potentially preventing both of these outcomes.
The impact report explains how The Centre for Epidemiology has pushed the boundaries of science to:
- spearhead current knowledge on the occurrence and progression of musculoskeletal conditions,
- improve the understanding of how arthritis and other musculoskeletal conditions progress over time,
- demonstrate the extent to which treatments for arthritis and other musculoskeletal conditions are effective and safe.
The showcase features keynote speakers Loreto Carmona (Institute of Musculoskeletal Health, Spain) and Gillian Hawker (University of Toronto, Canada), and is being held in the beautiful surroundings of the Whitworth Art Gallery in Manchester.
PhD students and early career researchers will have the opportunity to present their elevator pitches for their output or work plans and will have the benefit of 1-2-1 mentor advice from experienced senior researchers within musculoskeletal epidemiology.
Sarah Campbell, CEO of BSR, who is attending the showcase on Friday, commented, “This report of the fantastic work of the Centre for Epidemiology (VA), demonstrates just how invaluable the BSRBR-RA and JIA Registers are as a source of information that, over time, can be used to demonstrate how arthritis can be best treated, and opens the door for new treatments which will improve patient care”.